ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Zhanyu Pan
Matched on ORCID iD 0000-0001-7709-2941; OpenAlex author ID A5065506624. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportu… Last author DOI 10.1186/s12575-024-00254-1↗
- Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis. Last author DOI 10.1080/17474124.2023.2183497↗
- Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases. Last author DOI 10.1016/j.pan.2018.09.015↗
- Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care. Last author DOI 10.1016/j.pan.2017.07.002↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weidong Ma · 3 shared papers, 2017–2023 · strength 0.38
- Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
- Huaqiang Ouyang · 3 shared papers, 2017–2023 · strength 0.38
- Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
- Anna Sandström Gerdtsson · 1 shared paper, 2023 · strength 0.22
- Donglin Liu · 1 shared paper, 2023 · strength 0.22
- Bin Wang · 1 shared paper, 2024 · strength 0.20
- Weishuai Liu · 1 shared paper, 2024 · strength 0.20
- Yongjie Xie · 1 shared paper, 2024 · strength 0.20
- Manman Quan · 2 shared papers, 2017–2018 · strength 0.16
- Paper Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocar… DOI 10.1016/j.pan.2018.09.015↗
- Paper Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving pall… DOI 10.1016/j.pan.2017.07.002↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.